Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Mattia Lunardi, University of Galway
  • ,
  • Yves Louvard, Institut Cardiovasculaire Paris Sud
  • ,
  • Thierry Lefèvre, Institut Cardiovasculaire Paris Sud
  • ,
  • Goran Stankovic, University of Belgrade-School of Electrical Engineering
  • ,
  • Francesco Burzotta, University of South Florida
  • ,
  • Ghassan S Kassab, California Medical Innovation Institute
  • ,
  • Jens Flensted Lassen, Syddansk Universitet
  • ,
  • Olivier Darremont, Clinique Saint-Augustin-Elsan
  • ,
  • Scot Garg, Royal Blackburn Hospital
  • ,
  • Bon-Kwon Koo, Seoul National University
  • ,
  • Niels Ramsing Holm
  • Thomas W Johnson, University Hospitals Bristol NHS Foundation Trust
  • ,
  • Manuel Pan, Hospital Universitario Reina Sofia
  • ,
  • Yiannis S Chatzizisis, University of Nebraska Medical Center
  • ,
  • Adrian P Banning, Oxford University Hospitals NHS Foundation Trust
  • ,
  • Alaide Chieffo, San Raffaele Hospital, Milan
  • ,
  • Dariusz Dudek, Jagiellonian University Medical College
  • ,
  • David Hildick-Smith, Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany; Department of Cardiology, Swedish Medical Center, Seattle, Washington.
  • ,
  • Jérome Garot, Institut Cardiovasculaire Paris Sud
  • ,
  • Timothy D Henry, Carl and Edyth Lindner Center for Research and Education at the Christ Hospital
  • ,
  • George Dangas, The Zena and Michael A. Wiener Cardiovascular Institute, USA.
  • ,
  • Gregg Stone, The Zena and Michael A. Wiener Cardiovascular Institute, USA.
  • ,
  • Mitchell W Krucoff, From Guy's and St. Thomas' Hospitals, London (A.T.C.); the Department of Medicine, Stanford University, Stanford (R.A.H.), and Portola Pharmaceuticals, South San Francisco (B.L.W., A.G.) - both in California; the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School (S.Z.G.), and Beth Israel Deaconess Medical Center (C.M.G.) - both in Boston; the Faculty of Medicine, University of Calgary, Calgary, AB, Canada (R.D.H.); and the Division of Cardiology, Duke University and Duke Clinical Research Institute, Durham, NC (A.F.H.).
  • ,
  • Donald Cutlip, Harvard University
  • ,
  • Roxana Mehran, The Zena and Michael A. Wiener Cardiovascular Institute, USA.
  • ,
  • William Wijns, University of Galway
  • ,
  • Faisal Sharif, University of Galway
  • ,
  • Patrick W Serruys, University of Galway
  • ,
  • Yoshinobu Onuma, University of Galway

The Bifurcation Academic Research Consortium (Bif-ARC) project originated from the need to overcome the paucity of standardization and comparability between studies involving bifurcation coronary lesions. This document is the result of a collaborative effort between academic research organizations and the most renowned interventional cardiology societies focused on bifurcation lesions in Europe, the United States, and Asia. This consensus provides standardized definitions for bifurcation lesions; the criteria to judge the side branch relevance; the procedural, mechanistic, and clinical endpoints for every type of bifurcation study; and the follow-up methods. Considering the complexity of bifurcation lesions and their evaluation, detailed instructions and technical aspects for site and core laboratory analysis of bifurcation lesions are also reported. The recommendations included within this consensus will facilitate pooled analyses and the effective comparison of data in the future, improving the clinical relevance of trials in bifurcation lesions, and the quality of care in this subset of patients.

OriginalsprogEngelsk
TidsskriftEuroIntervention
ISSN1774-024X
DOI
StatusE-pub ahead of print - 18 maj 2022

Se relationer på Aarhus Universitet Citationsformater

ID: 272455348